Sean F. Scanlan - 09 Aug 2026 Form 4 Insider Report for TREACE MEDICAL CONCEPTS, INC. (TMCI)

Reporting relationship: Chief Innovation Officer
Issuer ticker: TMCI
Reported as of: 09 Aug 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 12 Aug 2026, 18:00:03 UTC
Prior SEC filing: 11 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Lisa Taylor as Attorney-in-fact for Sean Scanlan

Key filing fact

Sean F. Scanlan filed Form 4 for TREACE MEDICAL CONCEPTS, INC. (TMCI) on 12 Aug 2026.

Key facts

This page summarizes Sean F. Scanlan's Form 4 filing for TREACE MEDICAL CONCEPTS, INC. (TMCI).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 12 Aug 2026, 18:00.

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

CIK 0001856371 Primary reporting owner

Relationship: Chief Innovation Officer
Address: C/O TREACE MEDICAL CONCEPTS, INC., 100 PALMETTO PARK PLACE, PONTE VEDRA
Signature: /s/ Lisa Taylor as Attorney-in-fact for Sean Scanlan
Signature date: 12 Aug 2026

Shares, units, or other non-derivative securities reported in this filing.

TMCI transaction

Tax liability

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Explanation of responses 2 footnotes

Footnote F1

Includes 463,167 restricted stock units.

Footnote F2

Reflects the transfer of 15,000 shares of common stock to the reporting person's former spouse pursuant to a domestic relations order.